The major issues raised by the reviewers refer to the following points:
Thank you again for submitting your work to Molecular Systems Biology. We have now heard back from the three referees who agreed to evaluate your manuscript. As you will see from the reports below, the referees find the topic of your study of potential interest. However, they raise substantial concerns on your work, which should be convincingly addressed.
The major issues raised by the reviewers refer to the following points:
-several concerns are expressed with regard to the way MI is used in the present study to infer coevolution.
-the biological 'impact or role' or functional significance of the observed patterns of inter-PTM correlations should be investigated more in-depth. -the term 'crosstalk' appears to be ill-defined in the context of this study and should imperatively be replaced by more precise expressions.
-similarly, the presentation should be clarified and made more rigorous and the use of jargon terms should be avoided.
On a more editorial level, the datasets that are key to this study should be included in supplementary information to help others to reproduce and build upon this work. These datasets should include 1) the initial non-redundant compendium of PTM sites, 2) the matrix of computed Residue Conservation Scores and 3) the dataset of 'co-evolving' PTM pairs. *** PLEASE NOTE *** As part of the EMBO Publications transparent editorial process initiative (see our Editorial at http://www.nature.com/msb/journal/v6/n1/full/msb201072.html), Molecular Systems Biology will publish online a Review Process File to accompany accepted manuscripts. When preparing your letter of response, please be aware that in the event of acceptance, your cover letter/point-by-point document will be included as part of this File, which will be available to the scientific community. More information about this initiative is available in our Instructions to Authors. If you have any questions about this initiative, please contact the editorial office (msb@embo.org).
If you feel you can satisfactorily deal with these points and those listed by the referees, you may wish to submit a revised version of your manuscript. Please attach a covering letter giving details of the way in which you have handled each of the points raised by the referees. A revised manuscript will be once again subject to review and you probably understand that we can give you no guarantee at this stage that the eventual outcome will be favourable. PTMs and their associated networks is the foundation of cellular information processing and evolution of eukaryotes. Thus describing co-occurrences, evolution and network aspects of PTMs and their host proteins/domains is important and timely. Although our current knowledge of PTM sites are under-determined and by no means complete, there is enough data to facilitate a global analysis using sensitive statistics. The authors innovate unique and interesting scoring systems for analysis of couplings between PTMs. While the present manuscript does go in depth with this data space there are several important aspects left out which should be included. For example given the authors track-record in protein networks and domains it is striking how these aspects are missing from the paper.
Major Issues 1) Novelty wise, I do not think it shines strongly. We know there are a lot of cross-talk between PTMs but it would be useful to point to why some sites cross-talk or co-evolve other than those we know; this level of understand is missing. It would be important if the authors can somehow characterize the co-evolving residues they find.
2) I am not sure the authors correct for relatedness of species when analyzing co-evolving sites. It is also not clear the selection of species affect their result as it is well-accepted that the species used can affect co-evolving signal. This must be clarified as it could have profound implications for the results presented.
3) The authors state they perform redundancy reduction on their data. However it is unclear if this is only performed at the full-length sequence level? Did the authors also perform motif level or 'site level' redundancy reduction in order to make sure their mutual information and or counting exercises are not biased due to redundancy at the sequence level of the PTM sites, eg +-5 residues from the site. 4) Is the Mutual Information (MI) analysis performed in a way so the co-evolving domains are used to normalise the results? If not this could potentially heavily alter the conclusions of the paper. As shown in Jin J, ..., Pawson TP et al. Science Signaling 2009 and indeed papers from the authors themselves protein domains (modular) can co-evolve, this could easily have implications for the coevolution analysis and MI methods used and must be clarified.
5)
The authors refer to the PTM code. However, it would be useful if the paper could actually offer a suggestion for this and how it could be resolved. This would lift the paper significantly.
6) The representation of MI in fig.3A is completely incorrect. This important error makes one wonder if the authors fully understand MI. The right example in Fig.3A shows anticorrelation, but this is still a correlation and, unless the authors have implemented MI in a different manner than normal, the configuration shown there would lead to a high MI value! A low correlation and low MI would be achieved with completely random presence of amino acids. This is a major issue that must be dealt with.
7) The referee STRONGLY disagree it could be assumed conservation of site means conservation of PTM. One should rely on experimentally validated PTMs as much as possible (have a golden data set) and when not possible to use the golden set, use the extended set with extreme care and writing this is more prediction...
8)
Conservation seems to be used as a proxy for activity/function/... one can [and this had been done] argue lack of conservation does not involve lack of activity/function/... Conservation should just be considered as another feature.
9) The PTMs most likely 'cross talk' or co-evolve, are coupled however one would put it, only in order to perturb protein function. By only focusing on somewhat obscure concept of inter-PTM correlations the biological impact and role of this is lost. Thus it is not clear which biological role the patterns of co-occurence have. We know there are a lot of cross-talk between PTMs but it would be useful to point to why some sites cross-talk or co-evolve other than those we know; this level of understand is missing. It would be important if they can somehow characterize the co-evolving residues found. 10) While I liked the idea of finding patterns in proteins sharing PTMs. In fact, given that only 6000 proteins share PTMs and this is likely to be an underestimation given the data available, one wonders whether it could be explored whether other less-studied proteins have these same patterns and one could predict that they would also share PTMs.
Specific Issues
1) The term cross-talk. While somewhat popular in the community many thought leaders distance themselves to this imprecise and non-explanatory term. The referee strongly encourage the use of co-occurence, co-evolving, co-regulating, etc terms that the authors themselves use but not extensively enough. Cross-talk also refer more to co-modulation in terms of dynamics which is not study subject in this work.
2) The authors mention several numbers in their abstract. However, it is well known these are massively underestimated but one could also question the actual meaning of such numbers. It resembles the era of 'who got the longest' list kind of presentation and that is in the past. It would be more informative if the authors could mention more of the REAL results in their work in the abstract.
3) The authors write '(18, 21) implying a mechanistically different coupling." -Could it not be there is also cases where there is no coupling but rather co-evolution due to the overall evolution of the protein sequence? Not every pair got to perform cross-talk so to speak.
4) The authors state they did not want to go below the N=45 bound for statistical reasons. It should be well possible to lower this to 20 or even 12 using the appropriate tests.
5) The authors uses Interpro domains? this seems strange as SMART developed by the authors is a much more clean definition of protein modular domains and should give a better evolutionary signal.
6) It reads as if the quality control of the dataset was just removal of duplicates, which could be considered pre-processing and not part of assessment of quality of the data.
7)
The writing style is not always the best and perhaps the authors should re-consider rewriting at least part of the paper for clarity. 8) Opinions about the numbers should be kept to a minimum. Sentences like "almost 25% of the proteins in our dataset contain two or more modification types" (one could claim 25% is actually a low number unless there is data to support enrichment) or "to our surprise as many as 47,993 reveal an interplay between different PTM types" (why surprise?) do not help the article. 9) Concepts like interplay (repeated far too many times), cross-talk are ill-defined and used indistinguishably... This is the most comprehensive analysis of post-translational modifications that, to the best of my knowledge, has ever been done. While I could quibble with small details of some of the analyses, generally speaking, the methods were detailed, appropriate controls were included, data were correctly parsed for peptide properties (e.g. structured versus unstructured) and the scoring functions used accounted for over or underestimates of evolutionary rates. In and of itself this manuscript may be of interest to a broad community.
My one major issue is an obvious one: mutual information analysis never proves causal relationships and so I think the authors are out on a limb referring to mutual appearance of conserved residues as "cross-talk". The authors made some efforts to address this problem by looking, for instance, at the distance of PTM sites from each other or closeness in structure, but the evidence for some functional link between PTM sites is not strong one way or another. We could easily conclude simply that proteins that are regulated by one kind of PTM are likely to be regulated by another, but not necessarily at the same time and not necessarily effecting the same behaviors of the protein. So I'd prefer that the authors be more circumspect and describe their observations as suggesting potential crosstalk at most, but as likely suggesting multiple forms of regulation.
Reviewer #3 (Remarks to the Author):
Minguez et al. present the most comprehensive global analysis of PTMs to date. Overall this is a very poorly written paper replete with jargon and buzzwords. It is very difficult to discern what scientific claims/results are being presented, let alone evaluate whether they are supported by the data. Insofar as I can understand the analysis done, there are also several potential technical problems that need to be addressed.
1. Jargon/writing problems.
-'crosstalking' -this is not a word. crosstalk is a thing, therefore it's not grammatical to add 'ing' to the end.
-'We report here a novel framework that covers many proteins in multiple organisms to comparatively study the conservation of several PTM types and to systematically investigate their co-evolution as a proxy for coregulation (crosstalk) in conjunction with biological function.' This is incredibly vague. Is a 'novel framework' really the scientific contribution of the article? -'We not only quantify and extend known PTM type interplay' ... 'we derive functional context for many cases of PTM type crosstalk by identifying domains in which the interplay preferably occurs' ??? what is 'PTM type interplay'? Please explain simply what was found.
-'74,386 residues in 10,325 proteins are predicted to crosstalk and this is only counting the interplay in the proteins for which the sites have been experimentally verified;' How do the authors predict whether residues cross talk? If a protein has two modified residues, does this mean they 'crosstalk' ? This is not the usual use of the term crosstalk as in Stork & Schmitt, Trends Cell Biol. 2002 Jun; 12(6):258-66 or Lee et al., Cell. 2007 Dec 14; 131(6) :1084-96. This is very confusing and the authors should either remove the term crosstalk, or make it clear that they are not using it in the usual way.
2. Problems with the analysis.
-'Our results indicate that 14 out of the 35 PTM type pairs identified as crosstalking have their residues significantly closer in sequence or structure than comparable random residues ( Figure 4A and 4B).'
Shouldn't these be compared to 'non-cross talking residues', rather than random residues? It seems to me the result here is simply that modified residues are on average closer together than unmodified residues, both in primary sequence and structure. This seems to be a nice confirmation that the modified residues tend to cluster (this has been reported in several previous less comprehensive studies.) -One of the major findings seems to be that there are proteins with many PTM types. However, ~17K proteins have only 1 type and <5K (<25%) proteins have >1 type. What is the expectation here ? Is the <25% more than expected? -Part of the analysis depends on detecting co-evolution using mutual information: 'A systematic analysis of the co-evolution of each pair of PTM sites'. However, the authors have not cited (or apparently used) the standard methods for doing this. Below are a few citations related to using mutual information to detect co-evolution. As it stands, I am not convinced the authors are actually detecting coevolution. -'... conservation of a site implies conservation of the PTM. Indeed, this approach has been used to distinguish between functional and non-functional phosphorylation sites (Weinert et al, 2011) .'
This citation seems to be a mistake. Weinert et al's paper is called "Proteome-Wide Mapping of the Drosophila Acetylome Demonstrates a High Degree of Conservation of Lysine Acetylation." and they say: 'It appears that in most cases, phosphorylated serines and threonines are either not conserved or only marginally more conserved than serine and threonine residues that are not phosphorylated'. Perhaps the authors meant to use a different citation here.
-'if a modified serine is more conserved than the 95% of the non-modified serines in the respective protein (which is highly significant), we found that 17.7% of the experimentally determined human phosphosites of serine are significantly conserved' I don't understand this. Are they saying that they chose 95% as the cutoff to decide whether a modified serine is conserved or not?
1st Revision -authors' response 19 June 2012
We believe that we have satisfied the concerns of the reviewers (see the detailed point-by-pointresponse below). Regarding the points you highlighted as editor, we have clarified the use of mutual information, partially re-written the manuscript to improve the understanding of the work including a strict revision of the terminology used and added more detailed analyses of the functional roles where our predicted functional associations could be involved in. We specifically reply to each of your points below.
We believe we have now clarified the use of mutual information in our analysis in the responses to the reviewers, within the manuscript itself (page 3, paragraph 6) and in the Materials and Methods (page 10, paragraph 3, 'Extraction of co-evolving PTM pairs' section).
-the biological 'impact or role' or functional significance of the observed patterns of inter-PTM correlations should be investigated more in-depth.
To strengthen the functional significance of the pairs of co-evolving PTM types we also performed three new analyses:
1. A Gene Ontology enrichment analysis were we put all the pairs of co-evolving PTM types into context (page 4, paragraphs 3 and 4) with a lot of detailed information attached into 2 new tables in the Supplementary information (Supplementary datasets 4 and 5).
2. An analysis of the preferred functionality of proteins containing pairs of co-evolving PTM types that gives a global view of the processes that each of the predictions might contribute to (page 4, paragraph 3 and Supplementary Figure 13 ). 3. A characterization of co-evolving PTM types in terms of the network that their proteins are part of; this shows that they behave as functional modules (page 4, paragraph 3 and Supplementary Figure 12 ).
In addition to this, we have extended the manuscript by two more case studies where we characterize the co-regulation of the PTMs in depth in respect to particular functional processes. These complement the findings described in Supplementary tables 5 and 6 where we explore the role of pairs of PTM types in the regulation of i) protein functional tuning (PTMs associated to particular domains) and ii) protein binding (PTM pairs associated to short linear motifs).
The new examples described in the manuscript suggest a regulation of the nuclear localization of the NF-Kappa-B via the regulation of its subunit RelA by means of an extensive interplay between phosphorylated, methylated and acetylated residues (page 6, paragraph 2 and Figure 4D ), and a differential role of acetylated and SUMOylated residues interacting with the nuclear localization signal motif (page 6, paragraph 4 and Figure 4F and G).
-the term 'crosstalk' appears to be ill-defined in the context of this study and should imperatively be replaced by more precise expressions.
We have improved the accuracy of the terminology used in the manuscript, specifically abandoned the term "crosstalk" unless we cite articles and clearly distinguish our clearcut results (pairs of coevolving PTMs) from our predictions (functional association between PTMs or their co-regulation).
We have added an explanation on how we use the terms in page 3, paragraph 5.
We have re-written the parts of the manuscript were the reviewers pointed to a lack of accuracy or clarity and improved the language also more generally.
On a more editorial level, the datasets that are key to this study should be included in supplementary information to help others to reproduce and build upon this work. These datasets should include 1) the initial non-redundant compendium of PTM sites, 2) the matrix of computed Residue Conservation Scores and 3) the dataset of 'co-evolving' PTM pairs.
The data are provided as Supplementary Datasets 1, 2 and 3 as excel files.
We address each reviewer's concerns in a point-by-point-response below. Given these additional efforts to improve clarity and accuracy on the manuscript, together with the new analyses we added in the results part, we hope our explanations satisfy the concerns of the reviewers and will permit the publication of our manuscript in Molecular Systems Biology.
Reviewer #1 (Remarks to the Author):
Dear authors, PTMs and their associated networks is the foundation of cellular information processing and evolution of eukaryotes. Thus describing co-occurrences, evolution and network aspects of PTMs and their host proteins/domains is important and timely. Although our current knowledge of PTM sites are under-determined and by no means complete, there is enough data to facilitate a global analysis using sensitive statistics. The authors innovate unique and interesting scoring systems for analysis of couplings between PTMs.
We thank the reviewer for appreciating the importance and innovative aspects of this work.
While the present manuscript does go in depth with this data space there are several important aspects left out which should be included. For example given the authors track-record in protein networks and domains it is striking how these aspects are missing from the paper.
Most of our domain analysis is summarized in the Supplementary Table 5 that reports known and novel associations of protein domains and pairs of co-evolving PTMs. Due to the amount of data retrieved by this analysis we only described a case study in the manuscript, however in Supplementary Table 5 we address each of the results and evaluate the novelty of each of them by adding literature references where the regulation is described. In the revised version of the manuscript we have added a second case study in which we analyze the association of the IPT/TIG domain with co-evolving residues modified by phosphorylation, acetylation and methylation.
Regarding networks, we indeed did only explore a few network aspects and have now extended these.
Action Taken:
We have now added one more case study to the main text that describes the association of a protein domain with co-evolving PTMs (page 6, paragraph 2).
To introduce a network-based analysis of the regulation of proteins by co-evolving PTM types, we now characterize the topological parameters of the protein-protein interaction networks formed by set of proteins harboring a particular pair of co-evolving PTM types (page 4, paragraph 3 and Supplementary Figure 12 ). Our results show that proteins containing some of the co-evolving PTM types have higher connectivity between each other (other topological features were also analyzed) than both networks formed by proteins with modified, but not co-evolving residues and networks generated by random sets of proteins, suggesting that in some cases they might form functional modules.
We performed an extensive analysis of functional associations of co-evolving PTMs with protein domains and short linear motifs. A number of these are significant (see Supplementary tables 5 and 6) and provide directed hypotheses in the context of protein-protein interactions (motif associations) and protein functional tuning (domain associations). The results led to the identification of known and novel functional links of particular proteins in a specific context backed by a literature survey that independently provided the general framework in which the co-regulation could take place ( Supplementary Tables 5 and 6 ). As we find many significant, co-evolving PTMs that appear functionally associated, we have to concentrate on a few that can be characterized further so we only reported two case studies (that now have been extended to four). We also analyzed the preferred cell locations where the different combinations of co-evolving PTM types were found pointing to a proposal of the framework in which the co-evolution can be translated into functional links. We are aware that many more functional analyses can be done but there are also space limitations and we hope that we and others can explore the dataset generated here in more detail elsewhere.
We have included two more case studies into the text that explore in more detail the possible mechanisms of action of the co-regulations.
The new examples suggest i) a regulation of the nuclear localization of the NF-Kappa-B via the regulation of its subunit RelA by means of an extensive interplay between phosphorylated, methylated and acetylated residues (page 6, paragraph 2 and Figure 4D ), and ii) an association of SUMOylated and acetylated residues with the nuclear localization signal (NLS) where both, SUMOylation and acetylation, can be the first step of a signaling cascade for the nuclear translocation of proteins as they are found to be modifying the NLS motif in two proteins (PAPOLA and HDAD1 respectively). Details in page 6, paragraph 4 and Figure 4F and G.
As we understand that the domains and motifs associations only cover a subset of proteins containing particular pairs of co-evolving PTM types, we have added a Gene Ontology enrichment analysis that provides the functionalities in which the predicted co-regulations would take place (page 4, paragraphs 3 and 4 and Supplementary Datasets 4 and 5). Moreover, we have added an analysis of the preferred general functions to provide a more manageable and global context to our predictions (page 4, paragraph 3 and Supplementary Figure 13) .
In our analysis of conservation of PTM types we use for comparison orthologous proteins in the species used and correct for branch length effects per protein (i.e. much more fine-grained than only species distances), see description of the Residue Conservation Score algorithm for more details on its calculation.
For the calculation of the co-evolution score based on mutual information of two modified sites we provide a significance level for each of the pairs analyzed. The significance is calculated by permuting the species labels 100 times and then comparing the mutual information of the modified sites with the mutual information they would obtain in all possible tree scenarios. Only those pairs that obtain a score that is higher than 95% of the permuted values are considered as co-evolving for the next step, that is the evaluation of the global co-evolution of PTM types. We believe that by having as reference all possible phylogenetic scenarios we correct implicitly for the relatedness of the species in the analysis of each orthologous group.
We have added to the manuscript an explanation on how we calculate the statistical significance of the mutual information value for a pair of modified residues that is the approach we took to correct for the relatedness of species (page 3 and paragraph 6). This part was only in the Materials and Methods section before.
3) The authors state they perform redundancy reduction on their data. However it is unclear if this is only performed at the full-length sequence level? Did the authors also perform motif level or 'site level' redundancy reduction in order to make sure their mutual information and or counting exercises are not biased due to redundancy at the sequence level of the PTM sites, eg +-5 residues from the site.
The redundancy reduction indeed discards sequences that are identical or overlapping (peptides into protein sequences for example). If there are sequences in the dataset that have a shared motif, it would mean both share the same pattern for the modification strategy as it happens with some modification types (phosphorylation and N-linked glycosylation for instance) but it should not necessarily mean that they belong to the same orthologous group neither having the same function nor evolutionary conservation. Thus we believe that no redundancy reduction is required on the motifs specific to certain PTM types. If the reviewer means that two modifications can be placed inside one particular motif, then the co-evolution of the motif is indeed affecting the co-evolution of the PTMs (if they are both inside the motif). As they are part of the same functionality we believe those cases should not be excluded from the analysis as they are clear examples of functionally related PTMs. Furthermore, we discard pairs of PTMs that occur at the exact same site as obviously they will have the exact same evolutionary pattern.
We have added to the Materials and Methods section a more clear explanation on how we perform redundancy reduction in the protein sequences (page 8, paragraph 2). If two (or more) protein domains are co-evolving that is certainly a proof of functional association.
4) Is the Mutual Information (MI) analysis performed in a way
In the few cases where two PTMs are located inside two co-evolving domains within a protein there is a high probability that the two PTMs are also found co-evolving. We would still argue that the PTMs should also be considered as functionally associated as the PTMs would be modifying functionally associated domains, i.e. it would not alter the conclusions. In the very special case where the co-evolving domains are homologous domains (and the PTMs analyzed are located inside them) we think their association should be tagged as a more relaxed functional association although still an association as they are part of the same function.
5)
The task of deciphering a potential PTM code is a long term goal and the first step is to decipher PTM associations as we do in the present work. Those will be context-dependent which we cannot resolve here. Moreover, it would also require mechanistic insights into functional associations between PTMs which will vary a lot and go far beyond the scope of this manuscript. Our work is a high-throughput approach that aims to provide the first draft of the co-regulatory landscape of PTMs. In order to resolve a potential PTM code other data need to be generated to provide the resolution and context (spatial and temporal) to tackle mechanistic questions.
Action Taken:
We have modified the manuscript to make this point clearer (page 4, paragraph 4 and page 7, paragraph 4).
We think there could have been a misunderstanding as we do differentiate between correlation and anti-correlation as it is shown in Figure 3A and explained in materials and methods. For clarity, we use mutual information as implemented in Huynen (2000) and used in the STRING database to catch co-occurrences between genes across genomes.
For more clarity, we have added to the text that we do not treat correlation and anti-correlation in the same way (page 3, paragraph 6).
7)
The referee STRONGLY disagree it could be assumed conservation of site means conservation of PTM. One should rely on experimentally validated PTMs as much as possible (have a golden data set) and when not possible to use the golden set, use the extended set with extreme care and writing this is more prediction...
We agree with the reviewer in that comparing conservation between experimentally verified residues would be the most accurate approach to take, but unfortunately, due to the limitation in appropriate data, this would only allow to compare phosphorylated residues in very few species. As our aim is to characterize a more general landscape of protein modifications, we went for a more predictive approach that assumes site conservation as a proxy to PTM conservation as has been done in many 
Action Taken:
We have now more carefully phrased that we deal with a predictive component of our approach.
8) Conservation seems to be used as a proxy for activity/function/... one can [and this had been
done] argue lack of conservation does not involve lack of activity/function/... Conservation should just be considered as another feature.
Indeed, lack of conservation does not imply lack of activity, in fact in the discussion we highlight that point "residues that do not co-occur might also be co-regulated given the fast evolution of some sites" (page x, paragraph x). However, conservation is a good indicator for activity as used in traditional phosphorylation papers (Malik et al, 2006; Gnad et al, 2007; Holt et al, 2009; Tan & Bader 2012) , and we certainly will not find all associations as we point out in the discussion.
Action Taken:
We have re-written the manuscript to make this point even clearer (page 7, paragraph 4).
9) The PTMs most likely 'cross talk' or co-evolve, are coupled however one would put it, only in order to perturb protein function. By only focusing on somewhat obscure concept of inter-PTM correlations the biological impact and role of this is lost. Thus it is not clear which biological role the patterns of co-occurence have. We know there are a lot of cross-talk between PTMs but it would be useful to point to why some sites cross-talk or co-evolve other than those we know; this level of understand is missing. It would be important if they can somehow characterize the co-evolving residues found.
We thank the reviewer for this suggestion, which seems very similar to his/her point 1, thus see the answer to that point above.
As a functional overview (see also response to point 1), we have now included a deeper functional characterization of the pairs of co-evolving PTM types adding a Gene Ontology enrichment analysis that provides the functionalities in which the predicted co-regulations would take place (page 4, paragraphs 3 and 4, and Supplementary Datasets 4 and 5) and an analysis of the preferred general functions to provide a more manageable and global context to our predictions (page 4, paragraph 3 and Supplementary Figure 13 ). We have also included two more case studies into the text with a deeper explanation on the possible mechanisms of the co-regulations (page 6, paragraphs 2 and 4, Figure 4D , 4F and 4G) in which we highlight functional novelty and hypotheses at several levels.
10) While I liked the idea of finding patterns in proteins sharing PTMs. In fact, given that only 6000 proteins share PTMs and this is likely to be an underestimation given the data available, one wonders whether it could be explored whether other less-studied proteins have these same patterns and one could predict that they would also share PTMs.
We agree with the reviewer in that our associations to domains and motifs are by far underestimated as are the number of known PTMs. We also think a systematic search for patterns in proteins would permit the prediction of PTM sites in homologous proteins, but PTM prediction or PTM cross-talk inference by homology is out of the scope of the present work. Yet, we can provide a lower limit of the global network of functionally associated PTM types which on its own is a rich resource for detailed follow-ups as it harbor mostly undescribed individual functional associations.
We have re-written the manuscript to highlight that our results are far underestimated (page 7, paragraph 6).
Specific Issues
We agree with the reviewer that cross-talk is a common term, but ill-defined.
Action Taken:
We have therefore substituted the term cross-talk by more accurate terms that we more clearly define (page 3, paragraph 5): 'co-evolution' to define PTM pairs that have a significant mutual information value (calculated by means of co-occurrence over the phylogeny) and 'functional association', 'interplay' or 'co-regulation' to refer to our predictions of PTMs associated due to their co-evolution. The term 'cross-talk' is left for experimentally reported physical interactions between PTMs or cases where the authors themselves use it to describe an association.
We apologize for the lack of clarity in the abstract and have rephrased it. Although an underestimate, the numbers represent lower limits, but are enormous already and we find that this global message is one of our major findings. There is no other collection of such a dense network of functional associations between PTMs in the literature.
In response to the reviewer's suggestion we have re-written the abstract, phrased our findings more carefully and now explicitly mention that our findings are lower estimates (page 7, paragraph 4).
We believe the reviewer refers to this particular sentence in the manuscript: "The majority of observed PTM co-occurrences within proteins do not compete for the same type of amino acid (Danielsen et al, 2011; Wang et al, 2010 ) implying a mechanistically different coupling" in page 2, paragraph 3 (in the first version submitted, now paragraph 4). What we wanted to point out in here is that a potential functional association of two PTMs is not restricted to the competition for the same type of amino acid, thus there are more possible ways of two PTMs to co-operate for the same functionality.
We have re-written this sentence to improve its understanding (page 2, paragraph 4).
4)
The authors state they did not want to go below the N=45 bound for statistical reasons. It should be well possible to lower this to 20 or even 12 using the appropriate tests.
As we believed that in our statistical framework there is a lower limit in the number of residues a PTM type have to detect global co-evolution with other PTM types, we performed a simulation to test the behavior of our pipeline. According to the simulation (that assumes averaged parameters on the background residues) the limit to detect statistical significance depends on the number of residues from two different PTM types that are co-occurring within the same protein. Thus, even assuming that all the co-occurring residues are found co-evolving, we would need a higher cooccurrence of residues when we have fewer number of residues from one of the PTM types. In addition, a PTM type with more residues in the dataset could have more not co-evolving residues with other residues from other PTM type to be found significantly co-evolving, this also depends on the number of co-occurring residues within one protein, see figure below. For instance, assuming a co-occurrence with 5 phosphosites (average number for phosphorylated proteins, the by far largest PTM type in terms of residues) another PTM type would need to have (to be found significantly coevolving with phosphorylation) in the dataset:
• only 1 residue if we assume all pairs are found co-evolving (red line),
• 2 residues if we assume 1 not co-evolving pair per residue (orange line),
• 4 residues if 2 not co-evolving partners are found (green line)
• and up to 37 residues if 3 pairs are not found to be not co-evolving per residue (blue line).
The size that a PTM type need to have increases significantly if instead testing co-evolution with phosphorylation, any other PTM type (with less residues) is chosen. Therefore, we believe that adding more PTM types to the study (nitration was the next one in the list with 40 residues in 30 proteins) would not increase the number of globally co-evolving pairs of PTM types reported. This is indicated already by C-linked glycosylation (the PTM type with the smallest number of occurrences) as it does not reach any significant link as any link with another PTM would have to be very strong to be detectable.
Action Taken:
We have re-written the manuscript to add why our statistical framework does not allow PTM types with fewer residues that C-linked glycosylation to be included in the analysis (page 2, paragraph 3).
We have also added a Supplementary Figure 1 with the results of the simulation (same as above) and to the Materials and Methods section a detailed explanation of the methodology used to perform this analysis.
We decided to use Interpro domains as they cover a wider range of globular domains than SMART, which focuses mostly on signaling and mobile domains and contains rarely enzymes. SMART is part of Interpro, and have preference, but for this analyses a wide coverage is important.
We have added to the Materials and Methods section the reason that made us to select the Interpro database instead of other more curated databases (e.g. SMART), see page 11, paragraph 5.
We apologize for the misuse of the term 'quality control' in this sentence.
We have changed the text to say 'pre-processing' instead 'quality control' which it is in fact a better definition of what we do (page 2, paragraph 3).
7)
The writing style is not always the best and perhaps the authors should re-consider rewriting at least part of the paper for clarity.
We thank the reviewer for pointing out this as we think it is important for the global understanding of the results.
Action Taken:
We have now re-written some parts of the text to improve the clarity and accuracy of our statements.
8)
Opinions about the numbers should be kept to a minimum. Sentences like " almost 25% of the proteins in our dataset contain two or more modification types" (one could claim 25% is actually a low number unless there is data to support enrichment) or " to our surprise as many as 47,993 reveal an interplay between different PTM types" (why surprise?) do not help the article.
We apologize for the apparent abuse of this type of sentences.
Action Taken:
We have re-written the manuscript to avoid this kind of statements (page 2, paragraph 4 and page 3, paragraph 7). 9) Concepts like interplay (repeated far too many times), cross-talk are ill-defined and used&#x00A0;indistinguishably...
We agree with the reviewer that terms like 'cross-talk' or 'interplay' need a clear definition as they can be quite ambiguous.
We have re-written the manuscript limiting the use of cross-talk and interplay to their strict definitions and use other terminology to refer to our predictions. Please see response to point 1 in "specific issues" for an explanation of term usage. Fig.4A statistical significance of the difference required.
10)

Action Taken:
We have now re-made the figure including information on the statistical significance. 
Reviewer #2 (Remarks to the Author):
This is the most comprehensive analysis of post-translational modifications that, to the best of my knowledge, has ever been done. While I could quibble with small details of some of the analyses, generally speaking, the methods were detailed, appropriate controls were included, data were correctly parsed for peptide properties (e.g. structured versus unstructured) and the scoring functions used accounted for over or underestimates of evolutionary rates. In and of itself this manuscript may be of interest to a broad community.
My one major issue is an obvious one: mutual information analysis never proves causal relationships and so I think the authors are out on a limb referring to mutual appearance of conserved residues as " cross-talk" . The authors made some efforts to address this problem by looking, for instance, at the distance of PTM sites from each other or closeness in structure, but the evidence for some functional link between PTM sites is not strong one way or another. We could easily conclude simply that proteins that are regulated by one kind of PTM are likely to be regulated by another, but not necessarily at the same time and not necessarily effecting the same behaviors of the protein. So I'd prefer that the authors be more circumspect and describe their observations as suggesting potential crosstalk at most, but as likely suggesting multiple forms of regulation.
We thank the reviewer's appreciation of the work. Regarding the causality of co-evolution, we agree that causality is hard to show and we have re-written the manuscript in order to express more accurately the implications of our predictions. A functional association can be very broad to describe varies kinds of interdependencies between two PTMs and should thus capture the vast majority of observed instances.
Action Taken:
We have replaced terms like 'cross-talk' with more broader or explicit ones like functional association or co-evolution and added a clear explanation on the use of the terminology in the entire manuscript (page 3, paragraph 5).
Reviewer #3 (Remarks to the Author):
We were not aware that this was wrong as it had been used before by others (e.g. Donner, Nature Chemical Biology 2012) in this context. We apologize for this grammatical mistake.
Action Taken:
We have now replaced this term throughout the manuscript (including title and abstract) thus avoiding grammar issues.
-'We report here a novel framework that covers many proteins in multiple organisms to comparatively study the conservation of several PTM types and to systematically investigate their co-evolution as a proxy for coregulation (crosstalk) in conjunction with biological function.' This is incredibly vague. Is a 'novel framework' really the scientific contribution of the article?
We have now re-written the manuscript, including this part (page 2, paragraph 2), to be able to highlight our findings more clearly.
-'over 35 pairwise PTM type crosstalk' what does this mean ???
We apologize for this unclear statement. What we wanted to say is that we found 35 pairs of PTM types that globally co-evolve, which do not include pairs with the same type of modification, for instance phosphorylation-phosphorylation.
interplay in the proteins for which the sites have been experimentally verified;'
How do the authors predict whether residues cross talk? If a protein has two modified residues, does this mean they 'crosstalk' ? This is not the usual use of the term crosstalk as in Stork & Schmitt, Trends Cell Biol. 2002 Jun; 12(6):258-66 or Lee et al., Cell. 2007 Dec 14; 131(6):1084-96 . This is very confusing and the authors should either remove the term crosstalk, or make it clear that they are not using it in the usual way.
We agree that we used the word crosstalk far too many times where we only meant co-evolving, functional association or co-regulation.
Action Taken:
We have now limited its use to where it is a clear studied mechanism of co-operation or competence of PTMs and substituted it by "co-evolution" when we mean the outcome from our mutual information analysis and 'functional association', 'interplay' or 'co-regulation' when there is a prediction coming from that co-evolution. In order to improve the clarity and the general understanding of the work we have added a clear definition on the way we use terminology in the paper (page 3, paragraph 5).
Problems with the analysis.
Shouldn't these be compared to 'non-cross talking residues', rather than random residues?
It seems to me the result here is simply that modified residues are on average closer together than unmodified residues, both in primary sequence and structure. This seems to be a nice confirmation that the modified residues tend to cluster (this has been reported in several previous less comprehensive studies.)
We thank the reviewer for the constructive suggestion and have now performed an analysis accordingly. The results support our conclusion of co-evolving residues being closer in space and the statement is indeed stronger now.
Action Taken:
We re-analyzed the sequence and structure distances using modified but not co-evolving residues as background, please see new Figure 4A ,B and manuscript (page 5, paragraph 2). The comparison of distances against random residues (former Figure 4A and B) has been added to the Supplementary information ( Supplementary Figure 14 ).
-One of the major findings seems to be that there are proteins with many PTM types. However, ~17K proteins have only 1 type and <5K (<25%) proteins have >1 type. What is the expectation here ? Is the <25% more than expected?
Indeed, we did not evaluate whether proteins have many PTM types but just explored their cooccurrences within proteins ( Figure 1C ).
To answer the reviewer question, we include an extra figure (see below) with the evaluation of the number of PTMs and number of unique PTM types compared to the expectation of a random distribution of such modifications in our set of proteins.
To build the expected distributions we randomly assigned the modifications we have in our dataset to the proteins in each of the species in the study. Thus, we firstly compared the expected distribution of the number of proteins with particular number of PTMs to the real distribution in our dataset using the non-parametric Kolmogorov-Smirnov test. Thus, in the species with more experimentally verified PTMs (human, mouse, yeast, drosophila and cow) we see a significant difference between the two distributions. While proteins in general have less PTMs than expected, there are few proteins that have far more PTMs than expected which again suggest the incompleteness of the current knowledge of PTMs as the proteins with more PTMs are surely the more studied ones as shown in Figure 1C .
Furthermore, to see whether proteins have more unique PTM types than expected, we performed a Fisher exact test to evaluate whether the number of proteins with more than one PTM type in our dataset is more than expected (random assignment of PTMs). Here we found that proteins have systematically less PTM types than expected probably due to either the nature of PTMs that might be co-regulating more among the ones that are of the same type (eg. several phosphorylations are needed to activate a protein) or due to the nature of the experiments as they are obviously focused on a specific type of PTM which again suggests the incompleteness of the dataset.
Action taken:
We have added the conclusions of these two analysis to the manuscript (page 2, paragraph 4).
We have added the details of the methodology used to perform this analysis to the Materials and Methods section (page 8 and paragraph 7) and the results in the Supplementary Figure 3 (same as below).
We have now added more accurate references: Gnad et al, 2007; Holt et al, 2009; Tan & Bader 2012 (page 2, paragraph 5).
We apologize for the lack of clarity in this statement. Indeed we choose 95% as a cutoff value to describe a modified residue to be conserved, based on the whole distribution of conservation of nonmodified residues of the same amino acid within the same protein.
Action Taken:
We have now re-written this part as "we choose a rRCS of 95 as a cutoff to evaluate the conservation of a residue, meaning modified residue is more conserved than 95% of the nonmodified residues, we found that 17.7% of the experimentally determined human phosphosites of serine are significantly conserved" (page 3, paragraph 3).
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Thank you again for sending us your revised manuscript.
We are now satisfied with the modifications made and I am pleased to inform you that your paper has been accepted for publication.
Thank you very much for submitting your work to Molecular Systems Biology.
Sincerely,
Editor
Molecular Systems Biology
Reviewer #1 (Remarks to the Author):
I am happy with their replies. I think you should go ahead and publish.
